Subscribe to RSS - neb-meds


ABC Plus makes bid to revive neb-med biz


FORT PAYNE, Ala. – An increase in hospital readmissions for COPD patients could open the door for HME providers to re-enter a nebulizer medication market that has been dominated by national providers, says Marcus Kruk.

OIG: Lincare mostly complied with neb-med policies


CLEARWATER, Fla. – Lincare Pharmacy Services generally complied with Medicare requirements when billing for inhalation drugs, according to a new report from the Office of Inspector General.

ASP: Winners, losers, audits


BALTIMORE – With few exceptions, the average sales price (ASP) figures for nebulizer medications don’t change much from quarter to quarter. That doesn’t mean the market is stagnant, says Wayne Vega, senior vice president of the Inhalation Drug Group.

ASP: Budesonide gets big boost


BALTIMORE – Things are looking up for several respiratory medications in the latest average sales price (ASP) figures. For the fourth quarter 2013, budesonide (J7626) took the biggest leap, up 85 cents to $5.95 per dose.

IDG offers Ritedose of help


SOMERVILLE, N.J. – It’s not easy being a smaller provider of nebulizer medications in the world of “Big Pharma.”

Prices, audits stay the course


BALTIMORE – Brand-name Brovana took a hit in the latest average sales price (ASP) figures for nebulizer medications, but otherwise there were few major changes.